Sat 11 Sep 2010 5:12
Stocks in Brief

Peptech Limited

7 Mar 03 | Issue 122

All hopes of a painless settlement with Centocor over royalty payments have been lost. Centocor maintains that Remicade does not infringe Peptech's patents. Peptech has its lawyers warming up for action. It's down 38% since issue 120/Feb 02 (Steer Clear/Hold for the Upside - $1.70). With the prospect of a lengthy legal procedure, STEER CLEAR unless you have stuck with this one through thick and thin, in which case HOLD FOR THE UPSIDE.

If you enjoyed this article and wish to become a member before 30 June 2010, we?ve giving away over $200 in free gifts as part of our end of financial year special offer. You can find more information here.


What's this?

Related Articles

Brambles Limited
Stocks in Brief | 13 Aug 07 - Hold - $12.75
Coles Group Limited
Stocks in Brief | 10 Aug 07 - Comparative review
Westpac Banking Corporation
Stocks in Brief | 10 Aug 07 - Hold - $25.96
Fletcher Building Limited
Stocks in Brief | 10 Aug 07 - Take Part Profits - $10.77
West Australian Newspapers Holdings Limited
Stocks in Brief | 07 Aug 07 - Sell - $14.10
Sigma Pharmaceuticals Limited
Stocks in Brief | 06 Aug 07 - Buy - $1.750
The chairman is gone. Long live the chairman!
Stocks in Detail | 06 Aug 07 - Hold - $1.060
Mirvac makes others’ dreams come true
Stocks in Detail | 02 Aug 07 - Sell - $5.18
ARANA THERAPEUTICS | AAH
HOLD FOR THE UPSIDE
Price at review: $1.050
Most recent price: $1.395
Change since review: +32.86%